Biotech using engineered yeast to produce plant- and fungi-derived compounds for mental health therapies.
| Date | Round | Amount |
|---|---|---|
| Jul 2025 | Pre Seed Psylink raised €501K pre-seed led by Coinvest Capital to advance sustainable production of psychedelic compounds for mental health. | $581.8K |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.